| Role of serotonin receptor signaling in cancer cells and anti-tumor immunity S Karmakar, G Lal Theranostics 11 (11), 5296, 2021 | 77 | 2021 |
| Key activating and inhibitory ligands involved in the mobilization of natural killer cells for cancer immunotherapies S Karmakar, P Pal, G Lal ImmunoTargets and Therapy, 387-407, 2021 | 12 | 2021 |
| Th17 cell promotes apoptosis of IL-23R+ neurons in experimental autoimmune encephalomyelitis SA Sonar, HT Meitei, S Karmakar, A Mishra, S Inamdar, N Lenka, G Lal Clinical Immunology 259, 109898, 2024 | 1 | 2024 |
| Antagonism of Tachykinin receptor 1 promotes Foxp3+ regulatory CD4 T cells and controls gut mucosal inflammation G Lal, A Mishra, S Karmakar, N Halder, M Habib, D Kumar | | 2024 |
| Role of Serotonergic System in Regulating Brain Tumor-Associated Neuroinflammatory Responses S Karmakar, G Lal Neuroprotection: Method and Protocols, 181-207, 2024 | | 2024 |
| Effector and cytolytic function of natural killer cells in anticancer immunity S Karmakar, A Mishra, P Pal, G Lal Journal of Leukocyte Biology 115 (2), 235-252, 2024 | | 2024 |
| Novel combination of serotonin receptor (5-htr2b) antagonist and an immunomodulator and chemotherapeutic drugs for inhibition of cancer GL Surojit Karmakar IN Patent WO2023053142A1, 2023 | | 2023 |
Girdhari LalScientist, National Centre for Cell Science, Pune, IndiaAdresse e-mail validée de nccs.res.in
